enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.[ Read More ]
The intrinsic value of one NVNO stock under the base case scenario is HIDDEN Compared to the current market price of 3.28 USD, enVVeno Medical Corporation is HIDDEN
Current Assets | 46.9 M |
Cash & Short-Term Investments | 46.4 M |
Receivables | 0 |
Other Current Assets | 511 K |
Non-Current Assets | 1.71 M |
Long-Term Investments | 0 |
PP&E | 1.68 M |
Other Non-Current Assets | 31 K |
Current Liabilities | 1.37 M |
Accounts Payable | 427 K |
Short-Term Debt | 676 K |
Other Current Liabilities | 268 K |
Non-Current Liabilities | 1.06 M |
Long-Term Debt | 1.06 M |
Other Non-Current Liabilities | 0 |
Revenue | 0 |
Cost Of Revenue | 546 K |
Gross Profit | -546 K |
Operating Expenses | 25.2 M |
Operating Income | -25.2 M |
Other Expenses | -1.72 M |
Net Income | -23.5 M |
Net Income | -23.5 M |
Depreciation & Amortization | 546 K |
Capital Expenditures | -33 K |
Stock-Based Compensation | 5.2 M |
Change in Working Capital | -616 K |
Others | -863 K |
Free Cash Flow | -18.9 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
8 months ago
Mar 13, 2024
|
Sell 51.8 K USD
|
Alavi Hamed
Chief Technology Officer |
- 8334
|
6.22 USD |
2 years ago
Aug 16, 2022
|
Bought 47.6 K USD
|
Duhay Francis
director: |
+ 7751
|
6.14 USD |
2 years ago
Jun 30, 2022
|
Bought 3.85 K USD
|
Shrivastava Sanjay
director: |
+ 1000
|
3.85 USD |
2 years ago
Jun 27, 2022
|
Bought 9.5 K USD
|
BERMAN ROBERT ANDREW
Chief Executive Officer |
+ 2500
|
3.8 USD |
2 years ago
Nov 19, 2021
|
Bought 14.9 K USD
|
BERMAN ROBERT ANDREW
CEO |
+ 2000
|
7.43 USD |
2 years ago
Nov 19, 2021
|
Bought 14.9 K USD
|
BERMAN ROBERT ANDREW
CEO |
+ 2000
|
7.43 USD |
3 years ago
Nov 16, 2021
|
Bought 15.7 K USD
|
BERMAN ROBERT ANDREW
CEO |
+ 2000
|
7.87 USD |
3 years ago
Nov 16, 2021
|
Bought 15.7 K USD
|
BERMAN ROBERT ANDREW
CEO |
+ 2000
|
7.87 USD |
3 years ago
Aug 25, 2021
|
Bought 10 K USD
|
Jenusaitis Matthew
Director |
+ 1300
|
7.7 USD |
3 years ago
Jun 16, 2021
|
Bought 12.5 K USD
|
Gray Robert
Director |
+ 2000
|
6.25 USD |
3 years ago
May 21, 2021
|
Bought 9.44 K USD
|
Glickman Marc H.
SVP & Chief Medical Officer |
+ 1600
|
5.9 USD |
3 years ago
May 18, 2021
|
Bought 16.4 K USD
|
BERMAN ROBERT ANDREW
Chief Executive Officer |
+ 3000
|
5.47 USD |
3 years ago
May 18, 2021
|
Bought 16.4 K USD
|
BERMAN ROBERT ANDREW
Chief Executive Officer |
+ 3000
|
5.47 USD |
3 years ago
May 17, 2021
|
Bought 50.6 K USD
|
Duhay Francis
Director |
+ 9492
|
5.33 USD |
4 years ago
Jun 11, 2020
|
Sell 39 K USD
|
Biodyne Holding, S.A.
|
- 100000
|
0.39 USD |
4 years ago
Jun 15, 2020
|
Sell 42 K USD
|
Biodyne Holding, S.A.
|
- 100000
|
0.42 USD |
4 years ago
Jun 16, 2020
|
Sell 64.5 K USD
|
Biodyne Holding, S.A.
|
- 150000
|
0.43 USD |
4 years ago
Jun 17, 2020
|
Sell 97.5 K USD
|
Biodyne Holding, S.A.
|
- 203100
|
0.48 USD |
4 years ago
Jun 18, 2020
|
Sell 27.7 K USD
|
Biodyne Holding, S.A.
|
- 61640
|
0.45 USD |
4 years ago
Jun 19, 2020
|
Sell 36.8 K USD
|
Biodyne Holding, S.A.
|
- 80000
|
0.46 USD |
4 years ago
Jun 22, 2020
|
Sell 29.1 K USD
|
Biodyne Holding, S.A.
|
- 63186
|
0.46 USD |
4 years ago
Jun 23, 2020
|
Sell 34.4 K USD
|
Biodyne Holding, S.A.
|
- 80000
|
0.43 USD |
4 years ago
Jun 24, 2020
|
Sell 23.3 K USD
|
Biodyne Holding, S.A.
|
- 55530
|
0.42 USD |
4 years ago
Jun 25, 2020
|
Sell 40 K USD
|
Biodyne Holding, S.A.
|
- 100000
|
0.4 USD |
4 years ago
Jun 26, 2020
|
Sell 30.4 K USD
|
Biodyne Holding, S.A.
|
- 80000
|
0.38 USD |
4 years ago
Jun 29, 2020
|
Sell 26.6 K USD
|
Biodyne Holding, S.A.
|
- 68094
|
0.39 USD |
4 years ago
Jul 01, 2020
|
Sell 17.1 K USD
|
Biodyne Holding, S.A.
|
- 45000
|
0.38 USD |
4 years ago
Jul 02, 2020
|
Sell 22.8 K USD
|
Biodyne Holding, S.A.
|
- 57000
|
0.4 USD |
4 years ago
Jul 06, 2020
|
Sell 2.52 K USD
|
Biodyne Holding, S.A.
|
- 6450
|
0.39 USD |
4 years ago
Jul 16, 2020
|
Sell 19 K USD
|
Biodyne Holding, S.A.
|
- 50000
|
0.38 USD |
4 years ago
Jul 17, 2020
|
Sell 19 K USD
|
Biodyne Holding, S.A.
|
- 50000
|
0.38 USD |
4 years ago
Jul 20, 2020
|
Sell 64.5 K USD
|
Biodyne Holding, S.A.
|
- 150000
|
0.43 USD |
4 years ago
Jul 21, 2020
|
Sell 22.5 K USD
|
Biodyne Holding, S.A.
|
- 50000
|
0.45 USD |
4 years ago
Jul 30, 2020
|
Sell 8 K USD
|
Biodyne Holding, S.A.
|
- 25000
|
0.32 USD |
4 years ago
Jul 31, 2020
|
Sell 1.7 K USD
|
Biodyne Holding, S.A.
|
- 5000
|
0.34 USD |
4 years ago
Aug 03, 2020
|
Sell 22.4 K USD
|
Biodyne Holding, S.A.
|
- 70000
|
0.32 USD |
4 years ago
Aug 14, 2020
|
Sell 15.5 K USD
|
Biodyne Holding, S.A.
|
- 50000
|
0.31 USD |
4 years ago
Aug 18, 2020
|
Sell 17 K USD
|
Biodyne Holding, S.A.
|
- 50000
|
0.34 USD |
4 years ago
Aug 19, 2020
|
Sell 15 K USD
|
Biodyne Holding, S.A.
|
- 50000
|
0.3 USD |
4 years ago
Aug 20, 2020
|
Sell 20.2 K USD
|
Biodyne Holding, S.A.
|
- 75000
|
0.27 USD |
4 years ago
Aug 21, 2020
|
Sell 28.5 K USD
|
Biodyne Holding, S.A.
|
- 75000
|
0.38 USD |
4 years ago
Jun 02, 2020
|
Sell 72.6 K USD
|
Biodyne Holding, S.A.
10 percent owner |
- 220000
|
0.33 USD |
4 years ago
Jun 03, 2020
|
Sell 1.21 K USD
|
Biodyne Holding, S.A.
10 percent owner |
- 3900
|
0.31 USD |
4 years ago
Jun 03, 2020
|
Sell 522 USD
|
Biodyne Holding, S.A.
10 percent owner |
- 1683
|
0.31 USD |
5 years ago
Jun 07, 2019
|
Sell 459 K USD
|
Biodyne Holding, S.A.
Director |
- 684813
|
0.67 USD |
5 years ago
Mar 12, 2019
|
Bought 25 K USD
|
BERMAN ROBERT ANDREW
Chief Executive Officer |
+ 18382
|
1.36 USD |
5 years ago
Mar 12, 2019
|
Bought 25 K USD
|
BERMAN ROBERT ANDREW
Chief Executive Officer |
+ 18382
|
1.36 USD |
5 years ago
Mar 12, 2019
|
Bought 25 K USD
|
BERMAN ROBERT ANDREW
Chief Executive Officer |
+ 21740
|
1.15 USD |
5 years ago
Mar 12, 2019
|
Bought 25 K USD
|
BERMAN ROBERT ANDREW
Chief Executive Officer |
+ 21740
|
1.15 USD |